Hm. Blottiere et al., UTILIZATION OF ACTIVATED U937 MONOCYTIC CELLS AS A MODEL TO EVALUATE BIOCOMPATIBILITY AND BIODEGRADATION OF SYNTHETIC CALCIUM-PHOSPHATE, Biomaterials, 16(6), 1995, pp. 497-503
The use of calcium phosphate biomaterials as a bone substitute necessi
tates the use of normative biocompatibility and biodegradation techniq
ues which must be fast, simple and reproducible. In the present study,
we have developed an in vitro model to study and to compare different
calcium phosphate ceramics. After activation with 1,25-dihydroxy-vita
min D-3 and phorbol 12,13-dibutyrate, the monoblastic U937 cells becam
e multinucleated, expressed tartrate-resistant acid phosphatase and se
veral markers of monocyte/macrophage differentiation. Activated U937 c
ells did not express the vitronectin receptor (VNR) (as revealed using
monoclonal antibodies 23C6 or 13C2) but around 25% of the cells were
strongly reactive with 211D, a novel monoclonal antibody that recogniz
es an osteoclast-specific membrane antigenic determinant. These cells
remain active/viable with hydroxyapatite (HA) or beta-tricarcium phosp
hate (beta-TCP) ceramics. In conclusion, activated U937 cells are good
candidates to use in a normative in vitro method to evaluate new biom
aterials.